Inappropriate prescribing of antimicrobial agents may result in considerable expense to the health care system.
It was noted in a 295-bed, acute-care medical center that ceftriaxone was being prescribed every 12 hours in what appeared to be a disproportionately large percentage of patients.
A drug use evaluation was conducted to determine the appropriateness of the prescribing of this agent.
Based on indication, it was determined that a significant number of patients receiving twice-daily dosing should receive once-daily dosing.
An educational effort directed to the medical staff was implemented via the pharmacy and therapeutics committee on the proper prescribing of ceftriaxone.
A follow-up drug use evaluation demonstrated appropriate prescribing in most situations, resulting in cost savings in excess of $25,000.
Mots-clés Pascal : Ceftriaxone, Antibactérien, Antibiotique, Prescription médicale, Coût, Evaluation, Economie santé, Hôpital, Etats Unis, Amérique du Nord, Amérique, Céphalosporine dérivé
Mots-clés Pascal anglais : Antibacterial agent, Antibiotic, Medical prescription, Costs, Evaluation, Health economy, Hospital, United States, North America, America, Cephalosporin derivatives
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 96-0017223
Code Inist : 002B02S02. Création : 01/03/1996.